4-Hydroxy-4-phenyl-1-tert-butoxycarbonylpiperidine, 98%, 2g

2-Phenylethanol, min 99%, for synthesis, 1L, glass packaging

2,3-Dichloroaniline, 98.0%, 500g

(2R)-3,4-Dihydro-2-phenyl-2H-pyrimido[2,1-b]benzothiazole, 100mg

Perfluorophenyl 4-morpholinobenzoate, 98%, 250mg

2-Methyl-2-phenylsuccinic acid, 1g

3,5-Bis(trifluoromethyl)benzyl Chloride>97.0%(GC)25g

Pyrrolidine-1-carboxamide, 95.0%, 250mg

Potassium (2,4-dimethylphenyl)trifluoroborate, 95.0%, 5g

rel-(3S,5R)-Dimethyl piperidine-3,5-dicarboxylate hydrochloride, 98%, 250mg

ACRIVASTINE, 95%, 100mg

n-Butyl acetate, ACS reagent, 1L

N-(3-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)BENZENESULFONAMIDE, 95%, 1g